8 Stocks on Jim Cramer’s Mad Money Recap: IBM, Corning, and AI Rally Strength
In this article, we will look at the stocks featured in Jim Cramer’s Mad Money recap as he discussed how the AI build-out could power the economy.
Becton Dickinson & Co (BDX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Diamond Hill Capital Ric Dillon | 93,361 | $14,679,150 | -53% | 0.09% |
| 2. | Leucadia National Ian Cumming And Joseph Steinberg | 9,316 | $1,464,754 | -27% | 0.01% |
| 3. | Bayforest Capital Theodoros Tsagaris | 9 | $1,415 | 0% | |
| 4. | Fisher Asset Management Ken Fisher | 0 | $0 | 0% | |
| 5. | Sivik Global Healthcare Krishen Sud | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $191.57 | 5,250 | $1,005,742.50 | 6,046 | 2025-08-11 | Filing | |
| $233.62 | 1,500 | $350,430.00 | 8,015 | 2025-02-10 | Filing | |
| $247.96 | 30 | $7,438.80 | 10,052 | 2019-04-16 | Filing | |
| $239.01 | 45 | $10,755.45 | 10,022 | 2018-06-22 | Filing | |
| $225.89 | 285 | $64,378.65 | 9,977 | 2018-04-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $151.94 | 74 | $11,243.56 | 21,159 | 2026-04-27 | Filing | |
| $156.83 | 75 | $11,762.25 | 21,233 | 2026-03-26 | Filing | |
| $181.84 | 75 | $13,638.00 | 21,308 | 2026-02-26 | Filing | |
| $182.61 | 953 | $174,027.33 | 36,763 | 2026-02-18 | Filing | |
| $202.73 | 75 | $15,204.75 | 16,431 | 2026-01-26 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 18,490,610 | $2,907,278,610 | 0.07% | |
| 2. | 15,317,242 | $2,408,329,960 | 0.13% | |
| 3. | 2,271,757 | $357,139,390 | 0.07% | |
| 4. | 2,070,929 | $325,612,163 | 0.08% | |
| 5. | 1,681,536 | $264,387,747 | 0.05% |
News See All
Becton, Dickinson and Company (NYSE:BDX) Q2 2026 Earnings Call Transcript
Operator: Hello, and welcome to BD's Second Fiscal Quarter 2026 Earnings Call.
10 Best Dividend Aristocrat Stocks to Buy in 2026
Dividends have always played an important role in generating equity total return.
14 Best Defensive Stocks to Invest In Now
The US economy has entered the final week of April navigating a precarious war-driven landscape that has fundamentally altered the outlook for both growth and monetary policy.
10 Healthcare Stocks with Highest Dividends
In December, CNBC reported that health-care job growth is propping up the labor market at a time when many other industries are struggling.
7 Most Undervalued Blue Chip Stocks to Invest In
Large-cap stocks have not exactly fallen out of favor, but the conversation around them has shifted.
Becton, Dickinson Recieves FDA Clearance for Surgiphor 1000 ml Irrigation System
Becton, Dickinson and Company (NYSE:BDX) is one of the world’s largest pure-play medical technology companies in the world.
13 Undervalued Dividend Aristocrats to Buy Now
Dividend strategies remain popular for several reasons. A big part of the appeal is the steady income they can provide.
Becton, Dickinson and Company (BDX): A Bull Case Theory
We came across a bullish thesis on Becton, Dickinson and Company on X.com by @MoneyShow. In this article, we will summarize the bulls’ thesis on BDX.
Citi Raises Becton Dickinson (BDX) PT to $198 after Life Sciences Sale Update
On February 11, Citi analyst Joanne Wuensch lifted her price recommendation on Becton, Dickinson and Company (NYSE:BDX) to $198 from $185.70 and maintained a Buy rating.